© 2004

Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis

  • Otto R. Hommes
  • Giancarlo Comi


  • Updates the reader on evolution in the MS field

  • New hypotheses and therapeutic options are presented


Part of the Topics in Neuroscience book series (TOPNEURO)

Table of contents

  1. Front Matter
    Pages I-XV
  2. N. Kalkers, F. Barkhof, L. Bergers, R. Van Schijndel, C. Polman
    Pages 41-47
  3. J. De Keyser, G. Ramsaransing, E. Zeinstra, N. Wilczak
    Pages 109-114
  4. A. Achiron, Y. Barak, M. Faibel, S. Miron, I. Kishner, M. Chen et al.
    Pages 119-128
  5. C. Pozzilli, P. Pantano, S. Di Legge, F. Caramia, M. C. Piattella, I. Pestalozza et al.
    Pages 129-133
  6. J. H. Simon, L. Jacobs, N. Simonian, The MS Collaborative Research Group
    Pages 135-139
  7. A. Van Der Goes, E. C. W. Breij, M. Kortekaas, K. Hoekstra, P. J. H. Jongen, C. D. Dijkstra et al.
    Pages 155-161
  8. T. Berger, P. Rubner, R. Egg, E. Dilitz, D. Stadlbauer, F. Deisenhammer et al.
    Pages 163-166

About this book


There is now evidence that irreversible brain damage accumulates very early in the course of multiple sclerosis. This book reviews the main neurobiological, magnetic resonance imaging, and clinical aspects of the early phases of the dis­ ease. Mechanisms ofirreversible axonal damage and the role played by the inter­ action of glia and the axon are highlighted. In contrast to what was believed for a long time, the sufficient availability of oligodendrocyte precursor cells to promote remyelination in acute lesions has now been demonstrated. For reasons not understood, this remyelination process fails or does not start, particularly in the chronic stages ofthe disease. These findings emphasize the importance of the "milieu" changes induced by an inflammatory process in limiting remyelination. However, first indications are that part of this inflammatory process may have a neuroprotective effect. Pathological studies in multiple sclerosis have now clearly demonstrated that destructive processes may be followed by recovery phases in such a way that myelin may be morphologically and functionally reconstituted. These findings provide the rationale for early treatment and emphasize the importance of clinical trials in early multiple sclerosis. Early treatment is one of the most important aspects in multiple sclerosis today.


brain magnetic resonance magnetic resonance imaging magnetic resonance imaging (MRI) neuropathology neuroprotection

Editors and affiliations

  • Otto R. Hommes
    • 1
  • Giancarlo Comi
    • 2
  1. 1.European Charcot FoundationNijmegenThe Netherlands
  2. 2.Department of NeurologyScientific Institute and University Ospedale San RaffaeleMilanItaly

Bibliographic information

  • Book Title Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis
  • Authors O.R. Hommes
    G. Comi
  • Series Title Topics in Neuroscience
  • DOI
  • Copyright Information Springer-Verlag Italia 2004
  • Publisher Name Springer, Milano
  • eBook Packages Springer Book Archive
  • Hardcover ISBN 978-88-470-0195-4
  • Softcover ISBN 978-88-470-2171-6
  • eBook ISBN 978-88-470-2117-4
  • Edition Number 1
  • Number of Pages XV, 199
  • Number of Illustrations 0 b/w illustrations, 0 illustrations in colour
  • Topics Neurology
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Consumer Packaged Goods